Victory Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $278M | Buy |
2,203,012
+41,918
| +2% | +$5.52M | 0.16% | 152 |
|
|
2026
Q1 | $301M | Sell |
2,161,094
-570,192
| -21% | -$79.8M | 0.19% | 124 |
|
|
2025
Q4 | $335M | Sell |
2,731,286
-109,808
| -4% | -$13.3M | 0.19% | 120 |
|
|
2025
Q3 | $315M | Buy |
2,841,094
+50,955
| +2% | +$5.79M | 0.18% | 120 |
|
|
2025
Q2 | $309M | Buy |
2,790,139
+319,122
| +13% | +$34M | 0.2% | 118 |
|
|
2025
Q1 | $277M | Sell |
2,471,017
-580,550
| -19% | -$59.9M | 0.28% | 82 |
|
|
2024
Q4 | $282M | Buy |
3,051,567
+489,955
| +19% | +$44.1M | 0.28% | 78 |
|
|
2024
Q3 | $215M | Sell |
2,561,612
-468,814
| -15% | -$35.8M | 0.21% | 110 |
|
|
2024
Q2 | $208M | Buy |
3,030,426
+737,109
| +32% | +$49.2M | 0.21% | 112 |
|
|
2024
Q1 | $168M | Sell |
2,293,317
-196,388
| -8% | -$15.1M | 0.16% | 134 |
|
|
2023
Q4 | $202M | Buy |
2,489,705
+178,536
| +8% | +$13.9M | 0.21% | 110 |
|
|
2023
Q3 | $173M | Buy |
2,311,169
+137,272
| +6% | +$10.6M | 0.2% | 116 |
|
|
2023
Q2 | $168M | Sell |
2,173,897
-204,654
| -9% | -$16.3M | 0.18% | 120 |
|
|
2023
Q1 | $197M | Buy |
2,378,551
+17,600
| +0.7% | +$1.46M | 0.22% | 106 |
|
|
2022
Q4 | $203M | Sell |
2,360,951
-147,980
| -6% | -$11.7M | 0.23% | 99 |
|
|
2022
Q3 | $155M | Buy |
2,508,931
+48,312
| +2% | +$3.05M | 0.18% | 130 |
|
|
2022
Q2 | $152M | Buy |
2,460,619
+158,356
| +7% | +$9.8M | 0.17% | 140 |
|
|
2022
Q1 | $137M | Buy |
2,302,263
+403,107
| +21% | +$25.8M | 0.14% | 167 |
|
|
2021
Q4 | $138M | Buy |
1,899,156
+309,064
| +19% | +$21.3M | 0.13% | 186 |
|
|
2021
Q3 | $111M | Sell |
1,590,092
-374,703
| -19% | -$26.3M | 0.11% | 233 |
|
|
2021
Q2 | $135M | Buy |
1,964,795
+520,313
| +36% | +$34.7M | 0.13% | 184 |
|
|
2021
Q1 | $93.4M | Buy |
1,444,482
+311,832
| +28% | +$20.1M | 0.1% | 283 |
|
|
2020
Q4 | $66M | Buy |
1,132,650
+165,963
| +17% | +$10M | 0.07% | 411 |
|
|
2020
Q3 | $61.1M | Sell |
966,687
-6,062
| -0.6% | -$420K | 0.08% | 383 |
|
|
2020
Q2 | $74.8M | Sell |
972,749
-1,156,241
| -54% | -$88.6M | 0.1% | 290 |
|
|
2020
Q1 | $159M | Buy |
2,128,990
+910,711
| +75% | +$62.9M | 0.13% | 207 |
|
|
2019
Q4 | $79.2M | Sell |
1,218,279
-107,920
| -8% | -$7.03M | 0.1% | 301 |
|
|
2019
Q3 | $84.1M | Buy |
1,326,199
+1,091,511
| +465% | +$71.4M | 0.11% | 267 |
|
|
2019
Q2 | $15.9M | Buy |
234,688
+14,266
| +6% | +$938K | 0.03% | 679 |
|
|
2019
Q1 | $14.3M | Buy |
220,422
+201,305
| +1,053% | +$13.4M | 0.03% | 638 |
|
|
2018
Q4 | $1.2M | Sell |
19,117
-127
| -0.7% | -$8.88K | ﹤0.01% | 1165 |
|
|
2018
Q3 | $1.49M | Sell |
19,244
-569
| -3% | -$43K | ﹤0.01% | 1170 |
|
|
2018
Q2 | $1.4M | Sell |
19,813
-411
| -2% | -$29K | ﹤0.01% | 1166 |
|
|
2018
Q1 | $1.52M | Sell |
20,224
-22,758
| -53% | -$1.81M | ﹤0.01% | 1143 |
|
|
2017
Q4 | $3.08M | Sell |
42,982
-158,423
| -79% | -$12M | 0.01% | 904 |
|
|
2017
Q3 | $16.3M | Sell |
201,405
-78,965
| -28% | -$6.04M | 0.04% | 627 |
|
|
2017
Q2 | $19.8M | Buy |
280,370
+119,567
| +74% | +$7.96M | 0.05% | 578 |
|
|
2017
Q1 | $10.9M | Buy |
160,803
+62,693
| +64% | +$4.41M | 0.03% | 683 |
|
|
2016
Q4 | $7.03M | Buy |
98,110
+22,310
| +29% | +$1.66M | 0.02% | 733 |
|
|
2016
Q3 | $6M | Buy |
75,800
+10,910
| +17% | +$886K | 0.02% | 735 |
|
|
2016
Q2 | $5.41M | Sell |
64,890
-133,421
| -67% | -$11.8M | 0.02% | 560 |
|
|
2016
Q1 | $18.2M | Sell |
198,311
-295,040
| -60% | -$26.6M | 0.08% | 436 |
|
|
2015
Q4 | $49.9M | Sell |
493,351
-206,094
| -29% | -$21.4M | 0.21% | 152 |
|
|
2015
Q3 | $68.7M | Sell |
699,445
-87,780
| -11% | -$9.75M | 0.28% | 108 |
|
|
2015
Q2 | $92.2M | Sell |
787,225
-127,870
| -14% | -$14M | 0.34% | 80 |
|
|
2015
Q1 | $89.8M | Buy |
915,095
+110,258
| +14% | +$11.2M | 0.32% | 90 |
|
|
2014
Q4 | $75.9M | Buy |
804,837
+102,347
| +15% | +$10.6M | 0.28% | 105 |
|
|
2014
Q3 | $74.8M | Sell |
702,490
-321,921
| -31% | -$31.5M | 0.56% | 35 |
|
|
2014
Q2 | $84.9M | Sell |
1,024,411
-189,763
| -16% | -$14.8M | 0.58% | 33 |
|
|
2014
Q1 | $86M | Buy |
1,214,174
+410,724
| +51% | +$32.2M | 0.58% | 31 |
|
|
2013
Q4 | $60.4M | Sell |
803,450
-168,199
| -17% | -$11.7M | 0.43% | 52 |
|
|
2013
Q3 | $61.1M | Buy |
+971,649
| New | +$58.1M | 0.44% | 54 |
|
Other funds holding GILD
Victory Capital Management's GILD Position: Q2 2026 in Review
Victory Capital Management increased its Gilead Sciences (GILD) stake by 1.9% in Q2 2026, buying an estimated $5.52M and bringing the position to 2,203,012 shares worth $278M. The position accounts for 0.16% of the portfolio, ranked #152.
Victory Capital Management first reported a position in GILD in Q3 2013 and has held it in 52 quarters since. The position peaked at $335M in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Victory Capital Management held 2,203,012 shares of Gilead Sciences worth $278M as of Q2 2026.
- Victory Capital Management bought 41,918 Gilead Sciences shares in Q2 2026, an estimated $5.52M.
- Gilead Sciences made up 0.16% of Victory Capital Management's portfolio in Q2 2026, its #152 holding.
- Victory Capital Management first reported a position in Gilead Sciences in Q3 2013 and has held it in 52 quarters since.
- Victory Capital Management's Gilead Sciences position peaked at $335M in Q4 2025.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.